Hyderabad
Andhra Pradesh
58 Followers on Owler
Granules manufactures and distributes tablets, Pharmaceutical Formulation Intermediates, Active Pharmaceutical Ingredients and generic drugs...
Read moreGranules manufactures and distributes tablets, Pharmaceutical Formulation Intermediates, Active Pharmaceutical Ingredients and generic drugs...
Read moreNews
Mar 23, 2023
MarketScreener
Granules: Granules India : GCH concluded U S FDA audit
Mar 20, 2023
Owler
Granules India Limited: Granules's revenue changed from $453.70M in Sep 2022 to $458.25M in Dec 2022
Feb 27, 2023
The Hindu Business Line
Granules: Granules India gets USFDA nod for hypertension drug
Jan 24, 2023
The Hindu
Granules: Granules profit surges on higher paracetamol sales
Jan 24, 2023
Moneycontrol
Granules: Granules India Consolidated December 2022 Net Sales at Rs 1,146.13 crore, up 14.98% Y-o-Y
Jan 24, 2023
Moneycontrol
Granules: Paracetamol maker Granules India posts 23% rise in Q3 profit
Jan 16, 2023
MarketScreener
Granules: Granules India : Analysts/Institutional Investor Meet/Con. Call Updates
Jan 16, 2023
Indian Pharma Post
Granules: Granules India's Gagillapur facility completes USFDA inspection
Jan 03, 2023
Marketscreener
Granules: Granules India Limited Enters into a Strategic Partnership with Greenko ZeroC to Collaborate for Green Molecule Solutions
Jan 03, 2023
The Hindu
Granules: Granules plans to set up 2,000-cr. 'green' pharma unit in A.P.
Looking for similar companies to Granules?
Granules Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$458.2M
Granules's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 1.6B. Over the last four quarters, Granules's revenue has decreased by 40.1%. Specifically, in Q1 2022's revenue was $74.7M; in Q2 2022, it was $117.4M; in Q3 2022, it was $141.5M; in Q4 2022, Granules's revenue was $124.6M.
Granules News
Granules Press Releases
Granules Headquarters
My Home Hub,Madhapur 2nd Floor, 3rd Block
Hyderabad, Andhra Pradesh500 081
91-40-3066-0000
Driving Directions »Granules Summary
ABOUT
Overview
Granules manufactures and distributes tablets, Pharmaceutical Formulation Intermediates, Active Pharmaceutical Ingredients and generic drugs. Granules was founded in 1984. Granules' headquarters is located in Hyderabad, Andhra Pradesh, IN 500 081. Gr...CEO
Granules's Managing Director, Krishna Prasad Chigurupati, currently has an approval rating of 81%. Granules's primary competitors are MSN Laboratories, Gland Pharma, Neuland and 4 more.Website
granulesindia.comCompetitors
View 7 Granules competitors here.Acquisitions
View 1 companies acquired by Granules here.Funding
Funding data cannot be found related to GranulesInvestments
Recent investment data cannot be found related to GranulesFrequently Asked Questions about Granules
When was Granules founded?
Granules was founded in 1984Who is Granules's CEO?
Granules's CEO is Krishna Prasad ChigurupatiHow much revenue does Granules generate?
Granules generates $458.2M in revenueHow much funding does Granules have?
Granules has historically raised $0 in funding
Where is Granules's headquarters?
Granules's headquarters is in Hyderabad Andhra Pradesh, INHow many employees does Granules have?
Granules has 5,427 employeesWho are Granules's competitors?
Granules's top competitors are MSN Laboratories, Gland Pharma, Neuland